Sanofi in 1 story
The narratives SAN.PA currently appears in, with its side and exposure in each.
Bull side
0 storiesNo bull-side stories for SAN.PA yet.
Bear side
1 story- America Imports the World's Drug Prices
SAN.PA in “America Imports the World's Drug Prices”
StableExposure: not rated yetUS reference pricing puts global blockbuster economics—and not just American list prices—under pressure.
Dupixent and Sanofi's specialty pipeline face lower peak-sales assumptions if US prices converge toward overseas levels.